HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colchicine-induced myoneuropathy in childhood.

AbstractUNLABELLED:
Colchicine is used in the treatment of gouty arthritis, familial Mediterranean fever, amyloidosis, Behcet disease and dermatoses. Myoneuropathy is a rare side-effect reported either with intoxication or in elderly patients with chronic renal insufficiency causing elevated plasma drug levels. We report the first two cases of myoneuropathy in children, both taking appropriate doses of colchicine, and having normal renal function. The myoneuropathic changes were reversible after stopping treatment. The cause of colchicine myoneuropathy is unclear.
CONCLUSION:
In children treated with colchicine, neuromuscular phenomena of unknown aetiology may be related to the drug, even with a lack of intoxication or renal insufficiency.
AuthorsL Harel, M Mukamel, J Amir, R Straussberg, A H Cohen, I Varsano
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 157 Issue 10 Pg. 853-5 (Oct 1998) ISSN: 0340-6199 [Print] Germany
PMID9809829 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Gout Suppressants
  • Colchicine
Topics
  • Adolescent
  • Child, Preschool
  • Colchicine (adverse effects, therapeutic use)
  • Familial Mediterranean Fever (drug therapy)
  • Female
  • Gout Suppressants (adverse effects, therapeutic use)
  • Humans
  • Male
  • Neuromuscular Diseases (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: